Microvascular perfusion and transport in the diabetic heart

Microcirculation

Volumn 7, Issue 3, 2000, Pages 163-181

  McDonagh, Paul F ^a,c   Hokama, Jason Y ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Coronary blood flow; Coronary microcirculation; Diabetes; Heart; Inflammatory response; Ischemia reperfusion injury; Nitric oxide; Oxidative stress

Indexed keywords

NITRIC OXIDE;

ANIMAL; BLOOD CELL; BLOOD FLOW VELOCITY; CAPILLARY PERMEABILITY; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; DIABETES MELLITUS; DIABETIC ANGIOPATHY; EXPERIMENTAL DIABETES MELLITUS; HEART; HEART DISEASE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; METABOLISM; MICROCIRCULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; RAT; REPERFUSION INJURY; REVIEW; THROMBOCYTE ACTIVATION; VASODILATATION;

ANIMALS; BLOOD CELLS; BLOOD FLOW VELOCITY; CAPILLARY PERMEABILITY; CORONARY CIRCULATION; CORONARY VESSELS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HEART; HEART DISEASES; MICROCIRCULATION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRIC OXIDE; OXIDATIVE STRESS; PLATELET ACTIVATION; RATS; VASODILATION;

EID: 0034203487     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1549-8719.2000.tb00118.x     Document Type: Review

References (106)

1. Abbott RD, Donahue HP, Kannel WB, Wilson PWF. (1988). The impact of diabetes on survival following myocardial infarction in men vs women: the Framingham study. JAMA 260:3456-3460.
2. Al-Haboubi HA, Ward BJ. (1996). Effect of diabetes and acute high glucose concentration on vascular permeability of the isolated rat heart. Int. J Microcirc 16:206-207.
3. Andersen B, Goldsmith GH, Spagnuolo PJ. (1988). Neutrophil adhesive dysfunction in diabetes mellitus; the role of cellular and plasma factors. J Lab Clin Med 111:275-285.
4. Bagdade JD, Walters E. (1980). Impaired granulocyte adherence in mildly diabetic patients: effects of tolazamide treatment. Diabetes 29:309-311.
5. Bagdade JD, Stewart M, Walters E. (1978). Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes. Diabetes 27:677-681.
6. Bohlen HG, Lash JM. (1993). Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles. Am J Physiol 265: H219-H225.
7. Brass LF, Manning DR, Cichowski K, Abrams CS. (1997). Signaling through G Proteins in platelets: to the integrins and beyond. Thromb Haemost 78:581-589.
8. Bryszewska M, Watala C, Torzecka W. (1986). Changes in fluidity and composition of erythrocyte membranes and in composition of plasma lipids in type I diabetes. Brit J Haemotol 62:111-116.
9. Bucala R, Tracey KJ, Cerami A. (1991). Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invent 87:432-438.
10. 2+ content in platelets from a group of type II diabetic patients with macrovascular complications. Diabetes Care 18:60-63.
11. Center for Disease Control and Prevention. (1988). National Diabetes Fact Sheet: National estimates on diabetes in the U.S. Revised edition. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
12. Chatham JC, Forder JR, McNeill JH, Eds. (1996). The Heart in Diabetes. Kluwer Academic Publishers. Norwell, MA. 1-267.
13. Chung TW, Liu AG, Yu JH. (1993). Increased red cell rigidity might affect retinal capillary blood flow velocity and oxygen transport efficiency in type II diabetes. Diabetes Res 23:75-82.
14. Cosentino F, Luscher T. (1998). Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol 32:S54-S61.
15. Davi G, Gresele P, Violi F, Basili S, Catalano M, Giammarresi C, Volpato R, Nenci GG, Ciabattoni G, Patrono C. (1997). Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo: evidence derived from the study of peripheral arterial disease. Circulation 96:69-75.
16. Davis E, Ed. (1979). The Microcirculation in Diabetes. (Advances in Microcirculation Series, BM Altura, E Davis, H Harders, Eds.) S. Karger. Basel, Switzerland. 1-152.
17. Diederich D, Skopec J, Diederich A, Dai F-X. (1994). Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am J Physiol 266:H1153-H1161.
18. Factor SM, Minase T, Cho S, Fein F, Capasso JM, Sonnenblick EH. (1984). Coronary microvascular abnormalities in the hypertensive-diabetic rat. A primary cause of cardiomyopathy? Am J Pathol 116: 9-20.
19. Factor SM, Okun EM, Minase T. (1980). Capillary microaneurysms in the human diabetic heart. New Engl J Med 302:384-388.
20. Fischer VW, Barner HB, Leskiw ML. (1979). Capillary basal laminar thickness in diabetic human myocardium. Diabetes 28:713-719.
21. Forrat R, Sebbag L, Wiernsperger N, Guidollet J, Renaud S, de Lorgeril M. (1993). Acute myocardial infarction in dogs with experimental diabetes. Cardiovasc Res 27:1908-1912.
22. Fortes ZB, Farsky SP, Oliveira MA, Garcia-Leme J. (1991). Direct vital microscopic study of defective leukocyte-endothelial interaction in diabetes mellitus. Diabetes 40:1267-1273.
23. Freedman SF, Hatchell DL. (1992). Enhanced superoxide radical production by stimulated polymorphonuclcar leukocytes in a cat model of diabetes. Exp Eye Res 55:767-773.
24. Gaboury J, Woodman RC, Granger DN, Reinhardt P, Kubes P. (1993). Nitric oxide prevents leukocyte adherence: role of superoxide. Am J Physiol 265:H862-H867.
25. Gherasim L, Tasca C, Havriliuc C, Vasilescu C. (1985). A morphological quantitative study of small vessels in diabetic cardiomyopathy. Morphol Embryol 31:191-195.
26. Harris AG, Skalak TC, Hatchell DL. (1994). Leukocyte-capillary plugging and network resistance are increased in skeletal muscle of rats with streptozotocin-induced hyperglycemia. Int. J Microcirc 14:159-166.
27. Harris MI, Cowie CC, Stern MP et al., Eds. (1995). Diabetes in America. 2nd edition. NIH, NIDDKD. Washington, DC. Publication No. 95-1468. 1-733.
28. Hattori Y, Kawasaki H, Abe K, Kanno M. (1991). Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 261:H1086-H1094.
29. Hokama JY, Mullarkey PJ, Logan JJ, Cimetta AD, Leprince P, Goldman S, Copeland JG, McDonagh PF. (1999). Platelet-leukocyte interactions are increased in patients with type II diabetes. FASEB J 13:A660.
30. Hokama JY, Susa NJ, Copeland JG, McDonagh PF. (1997). The leukocyte response to diabetes is a function of disease duration. Diabetes 46(suppl 1): 196A.
31. Hokama JY, Ritter LS, Davis-Gorman G, Copeland JG, McDonagh PF. (1997). Diabetes enhances leukocyte accumulation in the coronary microcirculation early in reperfusion following ischemia. The Journal of Diabetes and Its Complications (in press).
32. Ihm S-H, Yoo HJ, Park SW, Park CJ. (1997). Effect of tolrestat, an aldose reductase inhibitor, on neutrophil respiratory burst activity in diabetic patients. Metabolism 46:634-638.
33. Inoue T, Fujito T, Asahi S, Hoshi K, Sakai Y, Morooka S. (1997). Impaired left ventricular diastolic filling occurs in diabetic patients without atherosclerotic coronary artery disease. Am J Med Sci 313: 125-130.
34. Jones SP, Girod WG, Granger DN, Palazzo AJ, Lefer DJ. (1999). Reperfusion injury is not affected by blockade of P-selectin in the diabetic mouse heart. Am J Physiol 277:H763-H769.
35. Joyner WL, Mayhan WG, Johnson RL, Phares CK. (1981). Microvascular alterations develop in Syrian hamsters after the induction of diabetes mellitus by streptozotocin. Diabetes 30:93-100.
36. Kannel WB, McGee DL. (1979). Diabetes and cardiovascular disease: the Framingham study. JAMA 241:2035-2038.
37. Kersten JR, Brooks LA, Dellsperger KC. (1995). Impaired microvascular response to graded coronary occlusion in diabetic and hyperglycemic dogs. Am J Physiol 268:H1667-H1674.
38. Knobler H, Savion N, Shenkman B, Kotev-Emeth S, Varon D. (1998). Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients. Thromb Res 90:181-190.
39. Koltai MZ, Hadházy P, Pósa I, Kocsis E, Winkler G, Rösen P, Pogátsa G. (1997). Characteristics of coronary endothelial dysfunction in experimental diabetes. Cardiovasc Res 34:157-163.
40. Kranidis A, Zamanis N, Mitrakou A, Patsilinakos S, Bonki T, Tountas N, Anthopoulos P, Raptis S, Anthopoulos L. (1997). Coronary microcirculation evaluation with transesophageal echocardiography Doppler in type II diabetics. Int J Cardiol 59:119-124.
41. Kubes P, Suzuki M, Granger DN. (1991). Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651-4655.
42. Kubota I, Fukuhara T, Kinoshita M, (1990). Permeability of small coronary arteries and myocardial injury in hypertensive diabetic rats. Int J Cardiol 29;349-355.
43. Leoncini G, Signorello MG, Piana A, Carrubba M. Armani U. (1997). Hyperactivity and increased hydrogen peroxide formation in platelets of NIDDM patients. Thromb Res 86:153-160.
44. Li C. (1992). Study on the capillary permeability of myocardium in diabetic rats. Chinese Journal of Pathology 21:183-185.
45. Liu Y, Thornton JD, Cohen MV, Downey JM, Schaffer SW. (1993). Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction. Circulation 88:1273-1278.
46. Mahgoub MA, Abd-Elfattah AS. (1998). Diabetes mellitus and cardiac function. Mol Cell Biochem 180:59-64.
47. Manciet LH, Copeland JG, Sexton WL. (1996). Effects of insulin treatment on diabetes-induced structural alterations of the heart. Microcirculation 3(1): 96.
48. Manciet LH, McDonagh PF, Poole DC, Mathieu-Costello O, Padilla K, Copeland JG. (1993). Coronary microvascular compression: a mechanism for no-reflow following myocardial ischemia. FASEB J 7:A894.
49. Martina V, Bruno GA, Trucco F, Zumpano E, Tagliabue M, Di Bisceglie C, Pescarmona G. (1998). Platelet cNOS activity is reduced in patients with IDDM and NIDDM. Thromb Haemost 79:520-522.
50. Bohlen HG. Cerebral microvascular control in normal, hypertensive and diabetic conditions, pp. 80-112 in: McDonagh PF, Ed. (1987). Microvascular Perfusion and Transport in Health and Disease. Karger. New York. 1-253.
51. McDonagh PF. (1993). The microvascular pathophysiology of chronic venous insufficiency. Yale J Biol Med 66:27-36.
52. McDonagh PF, Hokama JY, Copeland JG, Reynolds JM. (1997). The blood contribution to early myocardial reperfusion injury is amplified in diabetes. Diabetes 46:1859-1867.
53. McDonagh PF, Wilson DS, Iwamura H, Smith CW, Williams SK, Copeland JG. (1996). CD18 antibody treatment limits early myocardial reperfusion injury after initial leukocyte deposition. J Surg Res 64:139-149.
54. McGuire DK, Granger CB. (1999). Diabetes and ischemic heart disease. Am Heart J 138:S366-S375.
55. McLeod DS, Lefer DJ, Merges C, Lutty GA. (1995). Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol 147:642-653.
56. McMillan DE, Haley JA. (1988). The Microcirculation: changes in diabetes mellitus. Mayo Clin Proc 63:517-520.
57. McMillan DE. (1975). Deterioration on the microcirculation in diabetes. Diabetes 24:944-957.
58. Meyer C, Schwaiger M. (1997). Myocardial blood flow and glucose metabolism in diabetes mellitus. Am J Cardiol 80:94A-101A.
59. Mochizuki S, Ishikawa SI, Masakazu A. (1984). Insulin treatment and myocardial function in isolated, perfused heart from diabetic rat. Jpn Circ J 48:255-265.
60. Mohan IK, Das UN. (1998). Effect of L-arginine nitric oxide system on chemical-induced diabetes mellitus. Free Radic Biol Med 25:757-765.
61. Munro BH. (1997). Statistical Methods for Health Care Research. Third edition. Lippincott. Philadelphia. 1-444.
62. Nahser PJ Jr, Brown RE, Oskarsson H, Winniford MD, Rossen JD. (1995). Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 91:635-640.
63. Neumann F-J, Zohlnhöfer D, Fakhoury E, Ott I, Gawaz M, Schömig A. (1999). Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J Am Coll Cardiol 34:1420-1426.
64. Niu X, Smith CW, Kubes P. (1994). Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res 74:1133-1140.
65. Opie EH. (1991). The Heart. Physiology and Metabolism. Second edition. Raven Press. New York. 1-513.
66. Oskarsson HJ, Hofmeyer TG, Coppey L, Yorek MA. (1999). Effect of protein kinase C and phospholipase A2 inhibitors on the impaired ability of human diabetic platelets to cause vasodilation. Brit J Pharmacol 127:903-908.
67. Panes J, Kurose I, Rodriguez-Vaca D, Ariderson DC, Miyasaka M, Tso P, Granger DN. (1996). Diabetes exacerbates inflammatory responses to ischemia-reperfusion. Circulation 93:161-167.
68. Paulson DJ. (1997). The diabetic heart is more sensitive to ischemic injury. Cardiovasc Res 34:104-112.
69. Phillips C, Wilson D, Davis-Gorman C, McDonagh P. (1995). Compared to non-diabetics, diabetic hearts are less compromised by early reperfusion with blood. J Invest Med 43(suppl 1):103A.
70. Pinter GG, Lightman SL, Wilson PD, Yuen L, Bradbury MWB. (1991). Albumin escape from microvessels in kidney, heart and skeletal muscle in experimental diabetes mellitus in the anaesthetized rat. Exp Physiol 76:899-904.
71. Rennert G, Saltz-Rennert H, Wanderman K, Weitzman S. (1985). Size of acute myocardial infarcts in patients with diabetes mellitus. Am J Cardiol 55: 1629-1630.
72. Reynolds JM, Larsen JB, McDonagh PF. (1986). Diabetes decrease transcoronary exchange of macromolecules. Fed Proc. 45:1145.
73. Reynolds JM, McDonagh PF. (1987). Improved recovery from ischemia-reperfusion in the isolated diabetic rat heart. Fed Proc 46:727.
74. Rösen P, Du X, Tschope D. (1998). Role of oxygen derived radicals for vascular dysfunction in the diabetic heart: prevention by alpha-tocopherol? Mol Cell Biochem 188:103-111.
75. Rösen P, Ballhausen T, Stockklauser K. (1996). Impairment of endothelium dependent relaxation in the diabetic rat heart: mechanisms and implications. Diabetes Res Clin Pract 31:8143-8155.
76. Rossen JD. (1996). Abnormal microvascular function in diabetes: relationship to diabetic cardiomyopathy. Coronary Artery Disease 7:133-138.
77. Salas A, Panés J, Elizalde JI, Granger DN, Piqué JM. (1999). Reperfusion-induced oxidative stress in diabetes: cellular and enzymatic sources. J Leukoc Biol 66:59-66.
78. Salas A, Panés J, Rosenbloom CL, Elizalde JI, Anderson DC, Granger DN, Piqué JM. (1999). Differential effects of a nitric oxide donor on reperfusion-induced microvascular dysfunction in diabetic and non-diabetic rats. Diabetologia 42:1350-1358.
79. Sato H, Jordan JE, Zhao Z-Q, Sarvotham SS, Vinten-Johansen J. (1997). Gradual reperfusion reduces infarct size and endothelial injury but augments neutrophil accumulation. Ann Thorac Surg 64:1099-1107.
80. Schroder S, Palinski W, Schmid-Schönbein GW. (1991). Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Path 139:81-100.
81. Sebbag L, Forrat R, Canet E, Wiernsperger N, Delaye J, Renaud S, De Lorgeril M. (1994). Effect of experimental non-insulin requiring diabetes on myocardial microcirculation during ischaemia in dogs. Eur J Clin Invest 24:686-690.
82. Seitz S, Ali SS, Strödter D. (1993). Angioarchitecture in the heart of rats with streptozotozin-induced diabetes mellitus. Ann Anat 175:285-289.
83. Sexton WL, Poole DC, Mathieu-Costello O. (1994). Microcirculatory structure-function relationships in skeletal muscle of diabetic rats. Am J Physiol 266:H1502-H1511.
84. Shah SV, Wallin JD, Eilen SD. (1983). Chemiluminescence and superoxide anion production by leukocytes from diabetic patients. J Clin Endocrinol Metab 57:402-409.
85. Stamler J, Vaccaro O, Neaton JD, Wentworth D. (1993). Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16: 434-444.
86. Strauer BE, Motz W, Vogt M, Schwartzkopff B. (1997). Evidence for reduced coronary flow reserve in patients with insulin-dependent diabetes. A possible cause for diabetic heart disease in man. Exp Clin Endocrinol Diabetes 105:15-20.
87. Takeshita M, Ina K, Kitmura H, Shimada T, Nakamura M. (1997). Ultrastructural study of capillary and myocytic changes in the masseter and heart of KK-Ay mice. J Electron Microsc 46:413-423.
88. 2+ metabolism. Circ Res 62:931-940.
89. Tilton RG, Daugherty A, Sutera SP, Larson KB, Land MP, Rateri DL, Kilo C, Williamson JR. (1989). Myocyte contracture, vascular resistance, and vascular permeability after global ischemia in isolated hearts from alloxan-induced diabetic rabbits. Diabetes 38:1484-1491.
90. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. (1996). Vitamin C improves endothelium-dependent vasodilation in patients with noninsulin-dependeat diabetes mellitus. J Clin Invest 97:22-28.
91. Tooke JE. (1995). Perspectives in diabetes: microvascular function in human diabetes, a physiological perspective. Diabetes 44:721-726.
92. Tribulova M, Ravingerova T, Volkovova K, Ziegelhoffer A, Okruhlicova L, Ziegelhoffer B, Styk J, Slezak J. (1996). Resistance of diabetic rat hearts to Ca overload-related injury. Histochemical and ultrastructural study. Diabetes Res Clin Pract 31: S113-S122.
93. Tschoepe D, Driesch E, Schwippert B, Nieuwenhuis H-K, Gries FA. (1995). Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by nearnormoglycemia. Diabetes 44:890-894.
94. Wagner B, Fasching P, Schneider B, Kurzemann S, Waldhäus W, Lechner K, Kyrle PA. (1996). Platelet and endothelial cell function in patients with insulin-dependent diabetes mellitus with excellent, good, or poor metabolic control. Microvasc Res 52:183-187.
95. Ward BJ, Al-Haboubi HA. (1997). Structural changes in the cardiac microvasculature of the rat in response to acute high glucose levels: a comparison with diabetes. Microcirculation 4:429-437.
96. Watanabe A, Tomino Y, Yokoyama K, Koide H. (1993). Production of hydrogen peroxide by neutrophilic polymorphonuclear leukocytes in patients with diabetic nephropathy. J Clin Lab Anal 7:209-213.
97. 2) production and HBA1 level in diabetic patients. Diabetes Res Clin Pract 21:109-114.
98. 2) production by polymorphonuclear neutrophils from patients with diabetes mellitus. Folia Haematol (Leipzig) 112:658-668.
99. Williamson JB, Chang K, Rowold E, Marvel J, Tomlinson M, Sherman WR, Ackermann KE, Kilo C. (1986). Diabetes-induced increases in vascular permeability and changes in granulation tissue-levels of sorbitol, myo-inositol, chiro-inositol, and scyllo-inositol are prevented by sorbinil. Metabolism 35: 41-45.
100. Williamson JR, Kilo C. (1996). Basement-membrane thickening and diabetic microangiopathy. Diabetes 25(suppl. 2):925-927.
101. World Health Organization. (1997). World Health Report 1997: conquering suffering, enriching humanity. Geneva, Switzerland: World Health Organization.
102. Yamaji T, Fukuhara T, Kinoshita M. (1993). Increased capillary permeability to albumin in diabetic rat myocardium. Circ Res 72:947-957.
103. Yarom R, Zirkin H, Stämmler G, Rose AG. (1992). Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material. J Pathol 166:265-270.
104. Zatz R, Brenner BM. (1986). Pathogenesis of diabetic microangiopathy. The hemodynamic view. Am J Med 80:443-453.
105. Zhao G, Zhang X, Smith CJ, Xu X, Ochoa M, Greenhouse D, Vogel T, Curran G, Hintze TH. (1999). Reduced coronary NO production in conscious dogs after the development of alloxan-induced diabetes. Am J Physiol 277:H268-H278.
106. Zoneraich S. (1988). Small-vessel disease, coronary artery vasodilator reserve, and diabetic cardiomyopathy. Chest 94:5-7.